- Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
[作者:Fleshner, NE; Lucia, MS; Egerdie, B; Aaron, L; Eure, G; Nandy, I; Black, L; Rittmaster, RS,期刊:Lancet, 页码:1103-1111 , 文章类型: Article,,卷期:2012年379-9821]
- Background We aimed to investigate the safety and efficacy of dutasteride, a 5 alpha-reductase inhibitor, on prostate cancer progression in men with low-risk disease who chose to be followed up with active surveillance. ...
- Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial
[作者:Garcia, PJ; Holmes, KK; Carcamo, CP; Garnett, GP; Hughes, JP; Campos, PE; Whittington, WLH,期刊:Lancet, 页码:1120-1128 , 文章类型: Article,,卷期:2012年379-9821]
- Background Previous community-randomised trials of interventions to control sexually transmitted infections (STIs) have involved rural settings, were rarely multicomponent, and had varying results. We aimed to assess the...
|